Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06980649 · ClinicalTrials.gov registry record · Phase 1

Study of BHV-1300 in Graves' Disease

A Phase 1 study of Graves Disease, sponsored by Biohaven Therapeutics.

Recruiting
Registry status
Phase 1
Development phase
15
Enrollment target
13
Study locations

NCT06980649 is a Phase 1 study of Graves Disease that is actively recruiting participants, run by Biohaven Therapeutics. The registered enrollment target is 15 participants, below the 308-participant average among 11 other Graves Disease trials with a reported enrollment target (95% lower). The trial reports 13 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06980649, a Phase 1 study of Graves Disease, is actively recruiting participants, sponsored by Biohaven Therapeutics.

RECRUITING
Registry status
Phase 1
Development phase
15 participants
Enrollment target
13
Study locations

Study Summary

The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves' Disease and to explore its effect on disease-specific biomarkers.

Conditions Studied

Graves Disease

Interventions

  • DRUG BHV-1300

Study Locations (13)

Other

  • Site-004 - Fitzroy
  • Site-001 - Kotara
  • Site-003 - Melbourne
  • Site-010 - Oaklands Park
  • Site-008 - Parkville
  • Site-006 - St Leonards
  • Site-002 - Torquay

Texas

  • Site-106 - Houston
  • Site-101 - Houston
  • Site-105 - Shavano Park

California

  • Site-103 - South Gate

Florida

  • Site-100 - Miami

Georgia

  • Site-104 - Columbus

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-08-21
Est. Completion 2026-09
Phase Phase 1

Sponsor

Biohaven Therapeutics

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06980649

The ClinicalTrials.gov registry entry for NCT06980649 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 308-participant average among 11 other Graves Disease trials with a reported enrollment target (95% lower). The listed sponsor is Biohaven Therapeutics, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Graves Disease appearing as the primary indexed condition, and to 1 intervention - of which BHV-1300 is the first listed.

NCT06980649 reports 13 study locations spanning 5 distinct geographic areas - top geographies include Other, Texas, California.

Frequently Asked Questions

What is clinical trial NCT06980649 about?

NCT06980649 is a clinical study titled "Study of BHV-1300 in Graves' Disease". The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves' Disease and to explore its effect on disease-specific biomarkers.

What is the current status of trial NCT06980649?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2025-08-21. Estimated completion is 2026-09.

What conditions does trial NCT06980649 study?

This clinical trial studies the following conditions: Graves Disease.

What interventions are being tested in trial NCT06980649?

The interventions under investigation include: BHV-1300 (DRUG).

Who is sponsoring clinical trial NCT06980649?

This trial is sponsored by Biohaven Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06980649 being conducted?

This trial has 13 study locations across California, Florida, Georgia, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Graves Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Graves Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.